News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

RACHEL MURDOCK, PHARMD

Advertisement

Articles by RACHEL MURDOCK, PHARMD

Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug Users

ByRACHEL MURDOCK, PHARMD,MELISSA BADOWSKI, PHARMD, MPH, BCPS, AAHIVP
April 13th 2018

Unique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.

Advertisement

Latest Updated Articles

  • Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug Users
    Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug Users

    Published: April 13th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Top Infectious Disease News Stories Week of December 6 - December 12

2

Zoliflodacin Emerges as a First-in-Class Oral Option Against Drug-Resistant Gonorrhea

3

FDA Approves Zoliflodacin for Uncomplicated Urogenital Gonorrhea

4

"Complicating the Decision-Making" for the Universal Birth Dose of the Hepatitis B Vaccine

5

A Pediatrician’s Perspective on the Latest ACIP Hepatitis B Vaccine Recommendations

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us